View Older Stories View More Recent Stories

Aug 14, 2019 07:25AM Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update

Aug 7, 2019 08:30AM Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer

Jul 31, 2019 09:05AM Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies

Jul 31, 2019 08:30AM Vor Biopharma Appoints Dr. Bill Lundberg to Its Board of Directors

Jul 30, 2019 05:20PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Jul 26, 2019 07:27AM Solid Biosciences (SLDB) Announces $60 Million Private Placement of Common Stock and Warrants

Jul 26, 2019 07:25AM Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors

Jul 24, 2019 09:00AM Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection

Jul 15, 2019 09:00AM RA Capital Management Closes First Venture Fund

Jul 10, 2019 04:32PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Jun 25, 2019 09:00AM Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease

Jun 4, 2019 07:00AM Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference

May 15, 2019 04:51PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31

May 7, 2019 08:00AM Science2Startup Symposium Convened Close to 300 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections to Advance Scientific Innovation and Entre

May 2, 2019 09:03AM Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe M

Apr 24, 2019 04:43PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 24, 2019 09:00AM Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing

Apr 23, 2019 09:03AM Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal

Apr 15, 2019 04:36PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 12, 2019 07:00AM Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium

Apr 10, 2019 05:22PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 10, 2019 07:30AM Inozyme Pharma Raises $67 Million in Series A2 Financing to Develop Therapies for Rare Mineralization Disorders

Mar 27, 2019 04:00PM Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 14, 2019 09:03AM Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

Mar 7, 2019 08:00AM Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference

Feb 26, 2019 07:30AM Behind the Seizure™ Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures

Feb 20, 2019 08:00AM Peloton Therapeutics Secures $150 Million in Series E Financing

Feb 14, 2019 05:16PM Form SC 13G RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Myovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Spero Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Biohaven Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Kadmon Holdings, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:14PM Form SC 13G/A Krystal Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:01PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 14, 2019 02:00AM Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Feb 11, 2019 04:52PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 11, 2019 04:51PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:34PM Form 4 Wave Life Sciences Ltd. For: Jan 24 Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 23, 2019 08:38AM PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables

Jan 9, 2019 10:37PM Black Diamond Therapeutics Closes $85 Million Series B Financing

View More Recent Stories View Older Stories